This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02594/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02594/identifier/kegg-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02594/identifier/pubchem-compound/
n16http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB02594/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02594/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02594/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02594/identifier/chebi/

Statements

Subject Item
n2:DB02594
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02594 n16:DB02594
dcterms:title
2'-Deoxycytidine
adms:identifier
n8:617 n9:DB02594 n10:15698 n11:453557 n12:46508326 n13:C00881 n14:DCZ
n3:synthesisReference
Graham A. Mock, Douglas H. Lovern, "N.sup.4 -substituted 2'-deoxycytidine compounds, oligonucleotides including N.sup.4 -labeled 2'-deoxycytidines, and a process for making oligonucleotides with N-modified 2'-deoxycytidines." U.S. Patent US5633364, issued April, 1995.
n3:IUPAC-Name
n4:271B45F1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B45F7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B45F6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B45F3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B45F4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B45F5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B45EF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B45F0-363D-11E5-9242-09173F13E4C5 n4:271B45ED-363D-11E5-9242-09173F13E4C5 n4:271B4607-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B45EE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B45FD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B45FE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B45F8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B45F9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B45FB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B45FA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B45FC-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
951-77-9
n3:Bioavailability
n4:271B4603-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4605-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4606-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4602-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4601-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4604-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B45F2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B45FF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4600-363D-11E5-9242-09173F13E4C5